On November 26, 2013 the Association of Research- based Pharmaceutical Manufacturers in Bulgaria (ARPharM) adopted the Code for Disclosure of Transfers of Value by Pharmaceutical Companies to Healthcare Professionals and Health Organizations. The new Code requires from the beginning of 2016 all members of the organization to publicly disclose their financial relationships with healthcare professionals and health organizations. Thereby ARPharM joined the initiative of the European Federation of Pharmaceutical Industries and Associations, which adopted its Disclosure Code in June 2013.

Codes for disclosure are intended to introduce greater transparency on the interactions between the pharmaceutical companies and healthcare professionals. This cooperation is based on the exchange of scientific information between healthcare professionals and industry to provide the best possible treatment to patients. Adherence to high ethical standards in these relationships is a must. Pharmaceutical industry aims to ensure these standards by achieving a maximum degree of transparency as to keep relations industry - healthcare professionals well understood and appreciated by the health authorities and the public.

The Disclosure Code requires each company to document and disclose on its website:

1. Names of healthcare professionals and healthcare organizations that have received payments or other transfers of value.

2. The amounts of value transferred and relations to which it relates, such as congress fee, travel and accommodation, consultancy fees.

Download: ARPharM adopted the Code for Disclosure of Transfers of Value by Pharmaceutical Companies to Healthcare Professionals and Health Organizations